相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
Jing-Quan Wang et al.
DRUG RESISTANCE UPDATES (2021)
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle et al.
DRUG RESISTANCE UPDATES (2020)
ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance
Bruno C. Gomes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Chemoresistance mechanisms of breast cancer and their countermeasures
Xiwei Ji et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
J. A. Alberro et al.
LANCET ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma
Anna Reustle et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Drug resistance in topoisomerase-targeting therapy
Karol Wtorek et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2018)
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines
Haatisha Jandu et al.
BMC CANCER (2016)
Mechanisms Underlying Lung Resistance-Related Protein (LRP)-Mediated Doxorubicin Resistance of Non-Small Cell Lung Cancer Cells
Yu-Lun Chen et al.
CHINESE JOURNAL OF PHYSIOLOGY (2016)
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
Wen Li et al.
DRUG RESISTANCE UPDATES (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Multidrug Resistance Proteins (MRPs) and Cancer Therapy
Yun-Kai Zhang et al.
AAPS JOURNAL (2015)
Epigenetic control of meiotic recombination in plants
Natasha Yelina et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport-an Update
Qingcheng Mao et al.
AAPS JOURNAL (2015)
Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
Shumaila M. Bilgrami et al.
SPRINGERPLUS (2014)
Establishment of Paclitaxel-resistant Breast Cancer Cell Line and Nude Mice Models, and Underlying Multidrug Resistance Mechanisms in Vitro and in Vivo
Si-Ying Chen et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines
Wen-Jing Li et al.
MOLECULAR BIOLOGY REPORTS (2013)
Mechanisms regulating resistance to inhibitors of topoisomerase II
Ram N. Ganapathi et al.
FRONTIERS IN PHARMACOLOGY (2013)
Expression of the breast cancer resistance protein and 5-fluorouracil resistance in clinical breast cancer tissue specimens
Min Wang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Characterization and Resistance Mechanisms of A 5-fluorouracil-resistant Hepatocellular Carcinoma Cell Line
Wei Gu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Karthika Natarajan et al.
BIOCHEMICAL PHARMACOLOGY (2012)
EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors
Serge A. L. Zander et al.
PLOS ONE (2012)
New Topoisomerase I mutations are associated with resistance to camptothecin
Celine Gongora et al.
MOLECULAR CANCER (2011)
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
J. -U. Blohmer et al.
ANNALS OF ONCOLOGY (2010)
Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance
Hairong Huo et al.
CANCER RESEARCH (2010)
Prognostic Implications of and Relationship Between CpG Island Hypermethylation and Repetitive DNA Hypomethylation in Hepatocellular Carcinoma
Hwan Seok Lee et al.
CLINICAL CANCER RESEARCH (2009)
Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes
Stefanie Hauswald et al.
CLINICAL CANCER RESEARCH (2009)
Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
Federico Innocenti et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line
Fang Liu et al.
LIFE SCIENCES (2008)
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
Diego F. Calvisi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
Eva Bakos et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship
Ju-Mi Jeong et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2007)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer
JF Gagnon et al.
CLINICAL CANCER RESEARCH (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mechanisms of cellular resistance to camptothecins
G. L. Beretta et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Hepatocellular carcinoma: Molecular pathways and new therapeutic targets
LR Roberts et al.
SEMINARS IN LIVER DISEASE (2005)
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: A central European cooperative oncology group international, multicenter, prospective, randomized phase III trial
C Zielinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival
SD Heys et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: Results of a randomized, multicenter, phase III trial
JM Nabholtz et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
DNA methylation, chromatin inheritance, and cancer
MR Rountree et al.
ONCOGENE (2001)
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
SB Baylin et al.
HUMAN MOLECULAR GENETICS (2001)
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer
GL Scheffer et al.
CURRENT OPINION IN ONCOLOGY (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
AK Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
